2-28412074-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005253.4(FOSL2):c.607G>A(p.Ala203Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000132 in 152,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005253.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOSL2 | NM_005253.4 | c.607G>A | p.Ala203Thr | missense_variant | 4/4 | ENST00000264716.9 | NP_005244.1 | |
FOSL2 | XM_006711976.4 | c.658G>A | p.Ala220Thr | missense_variant | 4/4 | XP_006712039.1 | ||
FOSL2 | XM_006711977.4 | c.541G>A | p.Ala181Thr | missense_variant | 4/4 | XP_006712040.1 | ||
FOSL2 | XM_005264231.5 | c.*92G>A | 3_prime_UTR_variant | 5/5 | XP_005264288.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOSL2 | ENST00000264716.9 | c.607G>A | p.Ala203Thr | missense_variant | 4/4 | 1 | NM_005253.4 | ENSP00000264716.4 | ||
FOSL2 | ENST00000379619.5 | c.583G>A | p.Ala195Thr | missense_variant | 4/4 | 1 | ENSP00000368939.1 | |||
FOSL2 | ENST00000436647.1 | c.490G>A | p.Ala164Thr | missense_variant | 4/4 | 2 | ENSP00000396497.1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152060Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.607G>A (p.A203T) alteration is located in exon 4 (coding exon 4) of the FOSL2 gene. This alteration results from a G to A substitution at nucleotide position 607, causing the alanine (A) at amino acid position 203 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at